Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

exendin-4

  • You have access
    Glucagon-like Peptide-1 Receptor as Emerging Target: Will It Make It to the Clinic?
    Damian Wild, Kwadwo Antwi, Melpomeni Fani and Emanuel R. Christ
    Journal of Nuclear Medicine July 1, 2021, 62 (Supplement 2) 44S-50S; DOI: https://doi.org/10.2967/jnumed.120.246009
  • Optoacoustic Imaging of Glucagon-like Peptide-1 Receptor with a Near-Infrared Exendin-4 Analog
    You have access
    Optoacoustic Imaging of Glucagon-like Peptide-1 Receptor with a Near-Infrared Exendin-4 Analog
    Sheryl Roberts, Eshita Khera, Crystal Choi, Tejas Navaratna, Jan Grimm, Greg M. Thurber and Thomas Reiner
    Journal of Nuclear Medicine June 1, 2021, 62 (6) 839-848; DOI: https://doi.org/10.2967/jnumed.120.252262
  • Open Access
    PET-Based Human Dosimetry of 68Ga-NODAGA-Exendin-4, a Tracer for β-Cell Imaging
    Marti Boss, Mijke Buitinga, Tom J.P. Jansen, Maarten Brom, Eric P. Visser and Martin Gotthardt
    Journal of Nuclear Medicine January 1, 2020, 61 (1) 112-116; DOI: https://doi.org/10.2967/jnumed.119.228627
  • You have access
    Succinylated Gelatin Improves the Theranostic Potential of Radiolabeled Exendin-4 in Insulinoma Patients
    Mijke Buitinga, Tom Jansen, Inge van der Kroon, Wietske Woliner-van der Weg, Marti Boss, Marcel Janssen, Erik Aarntzen, Martin Béhé, Damian Wild, Eric Visser, Maarten Brom and Martin Gotthardt
    Journal of Nuclear Medicine June 1, 2019, 60 (6) 812-816; DOI: https://doi.org/10.2967/jnumed.118.219980
  • You have access
    Glucagon-Like Peptide-1 Receptor PET/CT with 68Ga-NOTA-Exendin-4 for Detecting Localized Insulinoma: A Prospective Cohort Study
    Yaping Luo, Qingqing Pan, Shaobo Yao, Miao Yu, Wenming Wu, Huadan Xue, Dale O. Kiesewetter, Zhaohui Zhu, Fang Li, Yupei Zhao and Xiaoyuan Chen
    Journal of Nuclear Medicine May 1, 2016, 57 (5) 715-720; DOI: https://doi.org/10.2967/jnumed.115.167445
  • You have access
    Development of 68Ga- and 89Zr-Labeled Exendin-4 as Potential Radiotracers for the Imaging of Insulinomas by PET
    Andreas Bauman, Ibai E. Valverde, Christiane A. Fischer, Sandra Vomstein and Thomas L. Mindt
    Journal of Nuclear Medicine October 1, 2015, 56 (10) 1569-1574; DOI: https://doi.org/10.2967/jnumed.115.159186
  • You have access
    Localization of Hidden Insulinomas with 68Ga-DOTA-Exendin-4 PET/CT: A Pilot Study
    Kwadwo Antwi, Melpomeni Fani, Guillaume Nicolas, Christof Rottenburger, Tobias Heye, Jean Claude Reubi, Beat Gloor, Emanuel Christ and Damian Wild
    Journal of Nuclear Medicine July 1, 2015, 56 (7) 1075-1078; DOI: https://doi.org/10.2967/jnumed.115.157768
SNMMI

© 2025 SNMMI

Powered by HighWire